Literature DB >> 11061594

Apoptosis induced in T cells by human neuroblastoma cells: role of Fas ligand.

G V Shurin1, V Gerein, M T Lotze, E M Barksdale.   

Abstract

The CD95/CD95L (Fas/Fas ligand) receptor/ligand system plays an important role in regulation of cell survival and induction of a programmed cell death. It is also involved in regulation of effector phase of T and NK cell cytotoxicity, establishment of immune privilege sites, and tumor escape from immune recognition. In this study, we assessed expression of CD95L in tumors obtained from patients with neuroblastoma (NB) and in established NB cell lines. We measured the presence of intratumoral T cell infiltrates and T cell survival in tumor tissue samples. High levels of apoptosis were observed in tumor-associated lymphocytes as well as in Jurkat T cells cocultured with NB cells in vitro. T cell death was reduced after treatment of NB cells (in vitro) with antibody to FAS ligand (FasL). Overall, our data suggest that NB-induced apoptosis of Fas-sensitive Jurkat T cells is mediated by functional FasL expressed on NB and Fas/FasL interaction may be responsible for the elimination of T cells in the NB microenvironment.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 11061594     DOI: 10.1159/000069452

Source DB:  PubMed          Journal:  Nat Immun        ISSN: 1018-8916


  7 in total

1.  Apoptosis and proliferation of acinar and islet cells in chronic pancreatitis: evidence for differential cell loss mediating preservation of islet function.

Authors:  A C Bateman; S M Turner; K S A Thomas; P R McCrudden; D R Fine; P A Johnson; C D Johnson; J P Iredale
Journal:  Gut       Date:  2002-04       Impact factor: 23.059

Review 2.  Neuroblastoma: developmental biology, cancer genomics and immunotherapy.

Authors:  Nai-Kong V Cheung; Michael A Dyer
Journal:  Nat Rev Cancer       Date:  2013-06       Impact factor: 60.716

3.  The microenvironment of human neuroblastoma supports the activation of tumor-associated T lymphocytes.

Authors:  Lena-Maria Carlson; Anna De Geer; Baldur Sveinbjørnsson; Abiel Orrego; Tommy Martinsson; Per Kogner; Jelena Levitskaya
Journal:  Oncoimmunology       Date:  2013-03-01       Impact factor: 8.110

4.  Combination of Id2 Knockdown Whole Tumor Cells and Checkpoint Blockade: A Potent Vaccine Strategy in a Mouse Neuroblastoma Model.

Authors:  Lina Chakrabarti; Clifford Morgan; Anthony D Sandler
Journal:  PLoS One       Date:  2015-06-16       Impact factor: 3.240

5.  Functional polymorphisms in FAS/FASL system increase the risk of neuroblastoma in Chinese population.

Authors:  Wei Han; Yuling Zhou; Rong Zhong; Chen Wu; Ranran Song; Li Liu; Li Zou; Yan Qiao; Kan Zhai; Jiang Chang; Liming Huang; Li Liu; Xuzai Lu; Jiao Lou; Dianke Yu; Wen Tan; Jinzhe Zhang; Huanmin Wang; Xiaoping Miao
Journal:  PLoS One       Date:  2013-08-12       Impact factor: 3.240

Review 6.  Targets and Antibody Formats for Immunotherapy of Neuroblastoma.

Authors:  Jeong A Park; Nai-Kong V Cheung
Journal:  J Clin Oncol       Date:  2020-03-13       Impact factor: 44.544

Review 7.  Neuroblastoma Origin and Therapeutic Targets for Immunotherapy.

Authors:  Irina V Kholodenko; Daniel V Kalinovsky; Igor I Doronin; Sergey M Deyev; Roman V Kholodenko
Journal:  J Immunol Res       Date:  2018-07-11       Impact factor: 4.818

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.